KAS
UTHR icon

Kestra Advisory Services’s United Therapeutics UTHR Stock Holding History

Kestra Advisory Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$734K Buy
1,355
+67
+5% +$37.7K ﹤0.01% 2037
2026
Q1 		$764K Hold
1,288
– – ﹤0.01% 1918
2025
Q4 		$628K Buy
1,288
+188
+17% +$87.6K ﹤0.01% 1980
2025
Q3 		$461K Sell
1,100
-166
-13% -$55.8K ﹤0.01% 2121
2025
Q2 		$364K Buy
1,266
+236
+23% +$70.5K ﹤0.01% 2212
2025
Q1 		$318K Sell
1,030
-127
-11% -$43.5K ﹤0.01% 2137
2024
Q4 		$408K Buy
1,157
+209
+22% +$76.8K ﹤0.01% 2016
2024
Q3 		$340K Sell
948
-244
-20% -$82.4K ﹤0.01% 2018
2024
Q2 		$380K Buy
1,192
+285
+31% +$75.4K ﹤0.01% 1968
2024
Q1 		$208K Buy
+907
New +$205K ﹤0.01% 2247
2023
Q1 		– Sell
-982
Closed -$273K – 2314
2022
Q4 		$273K Buy
+982
New +$248K ﹤0.01% 1807
2022
Q3 		– Sell
-1,052
Closed -$248K – 2243
2022
Q2 		$248K Buy
+1,052
New +$214K ﹤0.01% 1756

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Kestra Advisory Services's UTHR Position: Q2 2026 in Review

Kestra Advisory Services increased its United Therapeutics (UTHR) stake by 5.2% in Q2 2026, buying an estimated $37.7K and bringing the position to 1,355 shares worth $734K. The position accounts for ﹤0.01% of the portfolio, ranked #2037.

Kestra Advisory Services first reported a position in UTHR in Q2 2022 and has held it in 12 quarters since. The position peaked at $764K in Q1 2026. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Kestra Advisory Services held 1,355 shares of United Therapeutics worth $734K as of Q2 2026.
  • Kestra Advisory Services bought 67 United Therapeutics shares in Q2 2026, an estimated $37.7K.
  • United Therapeutics made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #2037 holding.
  • Kestra Advisory Services first reported a position in United Therapeutics in Q2 2022 and has held it in 12 quarters since.
  • Kestra Advisory Services's United Therapeutics position peaked at $764K in Q1 2026.
  • 882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.